FDA Drug recall D-0084-2024
Liothyronine Sodium Tablets, USP, 25 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512…
- FDA Drug
- Class II
- terminated
- Published 2023-11-08
On 2023-11-08 the FDA classified a Class II recall of Liothyronine Sodium Tablets, USP, 25 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512… by Sun Pharmaceutical Industries, citing failed Impurities/Degradation Specifications.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0084-2024 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2023-10-20 |
| Published | 2023-11-08 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Sun Pharmaceutical Industries |
| Distribution | US |
Product
Liothyronine Sodium Tablets, USP, 25 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191,(U.T. of D & NH), India. NDC 62756-590-88
Reason
Failed Impurities/Degradation Specifications.
Identifiers
| ndc | 62756-589-83 |
|---|---|
| ndc | 62756-589-01 |
| ndc | 62756-589-88 |
| ndc | 62756-589-08 |
| ndc | 62756-589-18 |
| ndc | 62756-590-83 |
| ndc | 62756-590-01 |
| ndc | 62756-590-88 |
| ndc | 62756-590-08 |
| ndc | 62756-590-18 |
| ndc | 62756-591-83 |
| ndc | 62756-591-01 |
| ndc | 62756-591-88 |
| ndc | 62756-591-08 |
| ndc | 62756-591-18 |
| code_info | Lot #: DNC2204A, Exp. Date 11/2023 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0084-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.